Target intelligence / Profile preview

RNA, U6 small nuclear 557, pseudogene (RNU6-557P)

Target
RNU6-557P
Molecular classification
Other
01

Overview

RNA, U6 small nuclear 557, pseudogene (RNU6-557P) is classified as a pseudogene corresponding to the U6 small nuclear RNA (snRNA) gene family[4][5]. U6 small nuclear RNA is an essential non-coding RNA involved in the spliceosome, the complex responsible for splicing pre-mRNA in eukaryotes[1][3]. However, RNU6-557P is a pseudogene—a non-functional genomic element that resembles its parent gene but contains mutations and structural differences that prevent it from producing a functional RNA or protein product[2][5]. Although some pseudogenes can exert regulatory roles, including serving as RNA templates for non-coding regulatory RNAs or miRNA decoys[2], there is no current evidence that RNU6-557P has a defined biological or disease-associated function, nor is it ever considered a drug target. Thus, it is primarily useful as a genomic marker rather than a therapeutic or functional molecule. Notes on this entry: - RNU6-557P is not a functional gene, receptor, or enzyme; it is a genomic pseudogene whose canonical product (if any) is non-functional and not involved in recognized biochemical pathways or therapeutic targeting[4][5]. - There are no drugs targeting this pseudogene, and it is not used as a biomarker in clinical or translational research[4]. - The entry is technically "incorrect" as a therapeutic target, as pseudogenes are not considered valid targets for pharmacological or genetic therapies, except in rare cases where regulatory roles are documented (not the case for this gene)[2][4].

Other names
RNU6-557P
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on RNA, U6 small nuclear 557, pseudogene (RNU6-557P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 557, pseudogene (RNU6-557P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call